TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.
Inclusion Criteria:
Exclusion Criteria:
1. Not willing or able to have additional blood samples collected
aries@tempus.com8007394137
Birmingham, Alabama 35233, United States
Amanda.Joseph@AlabamaOncology.com
Whittier, California 90605, United States
Norwich, Connecticut 06360, United States
kristine.bradbury@pihhealth.org562-698-0811 ext. 12341
jchamplin@echoct.com860-886-8362
Erin.Shepard@CSNF.us904-538-4488
justyn.dawson@msm.edu
Jeff.Whorton@piedmont.org
sarmad.nomani@sih.net
sgustafson@hopenheal.care
kzeisset@ccsci.net
cgeoffroy@illinoiscancercare.com
rbehrman@goshenhealth.com5743642649
cdrummond@frederick.health
Medeirossha@southcoast.org
lindsey.gander@hannibalregional.org573-629-3926
ashin@lakeregional.com
roger.holden@aoncology.com417-882-4880
ltapia@ccsreno.com775-329-0222
ncoleman@hoacny.com
drao@cayugamed.org607-252-3939
angela.bruns@sanfordhealth.org
carla.larch@aultman.com
jmartinez@toledoclinic.com
cvega@cancercareyork.com
Joy.Tinsen@ccnw.net
josselyn.molina@panoncologytrials.com